142 related articles for article (PubMed ID: 9883990)
1. Proliferative activity and steroid hormone receptor status in male breast carcinoma.
Muñoz de Toro MM; Maffini MV; Kass L; Luque EH
J Steroid Biochem Mol Biol; 1998 Nov; 67(4):333-9. PubMed ID: 9883990
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor expression inversely correlates with histological grade and N stage in ER
Scatena C; Scarpitta R; Innocenti L; Miccoli M; Biancotti R; Diodati L; Ghilli M; Naccarato AG
Breast Cancer Res Treat; 2020 Jul; 182(1):55-65. PubMed ID: 32436149
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.
Pich A; Margaria E; Chiusa L; Candelaresi G; Dal Canton O
Br J Cancer; 1999 Feb; 79(5-6):959-64. PubMed ID: 10070897
[TBL] [Abstract][Full Text] [Related]
4. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study.
Sasano H; Kimura M; Shizawa S; Kimura N; Nagura H
J Clin Endocrinol Metab; 1996 Aug; 81(8):3063-7. PubMed ID: 8768875
[TBL] [Abstract][Full Text] [Related]
5. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.
Riva C; Dainese E; Caprara G; Rocca PC; Massarelli G; Tot T; Capella C; Eusebi V
Virchows Arch; 2005 Oct; 447(4):695-700. PubMed ID: 16075292
[TBL] [Abstract][Full Text] [Related]
7. Steroid hormone receptor expression in male breast cancer.
Murphy CE; Carder PJ; Lansdown MR; Speirs V
Eur J Surg Oncol; 2006 Feb; 32(1):44-7. PubMed ID: 16260112
[TBL] [Abstract][Full Text] [Related]
8. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status.
Zhang X; Eliassen AH; Tamimi RM; Hazra A; Beck AH; Brown M; Collins LC; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):962-8. PubMed ID: 25855627
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z
Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
[TBL] [Abstract][Full Text] [Related]
10. Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast.
Magro G; Bisceglia M; Michal M
Histopathology; 2000 Jun; 36(6):515-21. PubMed ID: 10849093
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 expression in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Virchows Arch; 1998 Sep; 433(3):229-35. PubMed ID: 9769126
[TBL] [Abstract][Full Text] [Related]
12. Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach.
Brentani MM; Franco EL; Oshima CT; Pacheco MM
Int J Cancer; 1986 Nov; 38(5):637-42. PubMed ID: 3770993
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers.
Ogawa Y; Hai E; Matsumoto K; Ikeda K; Tokunaga S; Nagahara H; Sakurai K; Inoue T; Nishiguchi Y
Int J Clin Oncol; 2008 Oct; 13(5):431-5. PubMed ID: 18946753
[TBL] [Abstract][Full Text] [Related]
14. Hormone receptors in breast cancer: more than estrogen receptors.
Lamb CA; Vanzulli SI; Lanari C
Medicina (B Aires); 2019; 79(Spec 6/1):540-545. PubMed ID: 31864223
[TBL] [Abstract][Full Text] [Related]
15. Lack of relationship between the expression of Hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma.
Muñoz de Toro MM; Luque EH
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):277-84. PubMed ID: 9219918
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 expression and DNA fragmentation in breast carcinoma, pathologic and steroid hormone receptors correlates.
Diaz-Cano SJ; Garcia-Moliner M; Carney W; Wolfe HJ
Diagn Mol Pathol; 1997 Aug; 6(4):199-208. PubMed ID: 9360841
[TBL] [Abstract][Full Text] [Related]
17. Prolactin receptor expression in gynaecomastia and male breast carcinoma.
Ferreira M; Mesquita M; Quaresma M; André S
Histopathology; 2008 Jul; 53(1):56-61. PubMed ID: 18613925
[TBL] [Abstract][Full Text] [Related]
18. Orbital cavernous haemangiomas: immunohistochemical study of proliferative capacity, vascular differentiation and hormonal receptor status.
Gupta A; Prabhakaran VC; Dodd T; Davis G; Selva D
Orbit; 2012 Dec; 31(6):386-9. PubMed ID: 23088382
[TBL] [Abstract][Full Text] [Related]
19. Tracing differences between male and female breast cancer: both diseases own a different biology.
Kornegoor R; van Diest PJ; Buerger H; Korsching E
Histopathology; 2015 Dec; 67(6):888-97. PubMed ID: 25941088
[TBL] [Abstract][Full Text] [Related]
20. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
Keshgegian AA; Cnaan A
Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
